Research

Energy balance

Semaglutide treatment is not associated with higher rates of short-term adverse events after cervical spine decompression and fusion in patients with Type 2 Diabetes Mellitus.

Practitioners can consider that semaglutide treatment does not increase short-term surgical risks in this patient population.

StrongRefutesmedium confidence
This study suggests that in patients with T2DM, semaglutide treatment is not associated with higher rates of short-term adverse events after CSDF.
Tao Xu et al. · Spine · 2024

Why this rating

Based on a retrospective cohort study design with a matched analysis.

Source

No Difference in Short-term Surgical Outcomes From Semaglutide Treatment for Type 2 Diabetes Mellitus After Cervical Decompression and Fusion

Tao Xu et al. · Spine · 2024

DOI 10.1097/brs.0000000000005099

cohort · n=596Cited 15×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →